Quarterly report pursuant to Section 13 or 15(d)

Stock Options

v3.22.1
Stock Options
6 Months Ended
Feb. 28, 2022
Stock Options  
13. Stock Options

13.

Stock Options

 

The Company has established the Equity Incentive Plan whereby the board of directors may, from time to time, grant stock options up to the equivalent of 10% of the number of common shares issued and outstanding to directors, officers, employees, and consultants. Stock options granted must be exercised within five years from the date of grant or such lesser period as determined by the Company’s board of directors. The exercise price of an option is equal to or greater than the closing market price of the Company’s common shares on the day preceding the date of grant. The vesting terms of each grant are set by the board of directors. The Company did not grant any options during the quarter ended February 28, 2022.

 

A continuity schedule for stock options is presented below:

 

 

 

Options

 

 

Weighted Average Exercise Price $

 

 

Weighted Average Remaining Contractual Term (Years)

 

 

Aggregate Intrinsic Value $

 

Balance August 31, 2020

 

 

171,604

 

 

 

11.17

 

 

 

 

 

 

 

Cancelled/expired

 

 

(50,334 )

 

 

10.76

 

 

 

 

 

 

 

Granted

 

 

84,900

 

 

 

5.41

 

 

 

 

 

 

 

Balance August 31, 2021

 

 

206,170

 

 

 

8.90

 

 

 

 

 

 

 

Cancelled

 

 

(3,334 )

 

 

9.60

 

 

 

 

 

 

 

Granted

 

 

81,800

 

 

 

6.23

 

 

 

 

 

 

 

Balance February 28, 2022 (Outstanding)

 

 

284,636

 

 

 

8.12

 

 

 

3.61

 

 

 

-

 

Balance February 28, 2022 (Exercisable)

 

 

260,386

 

 

 

8.35

 

 

 

3.59

 

 

 

-

 

 

The fair value of share purchase options granted were estimated as of the date of the grant by using the Black-Scholes option pricing model with the following assumptions:

 

 

 

February 28,

2022

 

Expected volatility

 

 

119 %

Risk-free interest rate

 

 

0.85 %

Expected life

 

5 years

 

Dividend yield

 

 

0 %

Estimated fair value per option

 

$ 5.10